ArticleJournal of hepatocellular carcinoma2026
Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study.
Haozhe Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.